pipette
ENEnglish

ITLN1 suppresses colorectal cancer progression by orchestrating neutrophil maturation and spatial organization

Li Chen, Xiangwei Zhai, Shaoxiang Chen, Jie Luo, Jing Sun, Guibing Qiao, Chen Yang, Yan Zhang, Xiaoying Lou, Meng Kou, Liyan Guo, Ziyue Li, Dan Xie, Zheng Hu, Qizhou Lian

Revista con revisión por pares

En palabras de los autores

Abstract Epithelial-derived intelectin-1 (ITLN1) is frequently downregulated in colorectal cancer, but whether it actively shapes anti-tumor immunity remains unclear. We integrate multiplex immunohistochemistry, spatial analysis, single-cell transcriptomics, chromatin-accessibility profiling, and perturbation models to define how ITLN1 regulates neutrophil maturation and spatial anti-tumor immunity. In treatment-naïve human colorectal cancer, higher ITLN1 expression associates with greater neutrophil infiltration, shorter distances between mature S100A9 + CXCR2 + neutrophils and ITLN1 + tumor epithelial cells, and improved survival. In mouse colorectal cancer models, Itln1 silencing accelerates tumor growth and metastasis, impairs CXCR2 + CD101 + mature neutrophil generation and tumor recruitment, and promotes LTF + S100A9 + immature neutrophil accumulation in hypoxic regions. Mechanistically, ITLN1 activates a JAK1/STAT3-associated C/EBPδ program that drives terminal granulopoiesis and CXCR2-dependent tumor homing, while recombinant ITLN1 restores neutrophil maturation and tumor-killing activity. Here, we reveal a cross-tissue ITLN1–STAT3/C/EBPδ–CXCR2 axis that links epithelial ITLN1 to bone marrow granulopoiesis, coordinating distal neutrophil maturation, mobilization and spatial organization in colorectal cancer.

Resultado principalEl resumen no menciona limitaciones.

Apareció: domingo, 18 de octubre. Nature Communications. Revista con revisión por pares.

DOI: 10.1038/s41467-026-78599-2